Novo Nordisk wins US approval for weight-loss pill

The pill is 25 milligrams of semaglutide, the same active ingredient in injectable Wegovy and Ozempic, and will be sold under the brand name Wegovy. Novo already sells an oral semaglutide for type 2 diabetes, Rybelsus

from The Business Standard https://ift.tt/1kGP7vM